Catalogo dei prodotti della ricerca

DI COSTANZO, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.474
EU - Europa 768
AS - Asia 308
AF - Africa 21
SA - Sud America 13
OC - Oceania 6
Totale 2.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.461
IT - Italia 444
SG - Singapore 166
SE - Svezia 88
DE - Germania 79
CN - Cina 55
IN - India 55
GB - Regno Unito 31
BG - Bulgaria 29
FI - Finlandia 28
FR - Francia 21
ID - Indonesia 19
TG - Togo 18
AR - Argentina 12
CA - Canada 10
NL - Olanda 9
IE - Irlanda 7
IR - Iran 7
AU - Australia 5
RO - Romania 5
UA - Ucraina 5
CH - Svizzera 4
GR - Grecia 4
RU - Federazione Russa 4
BE - Belgio 3
HK - Hong Kong 3
MX - Messico 3
PL - Polonia 3
ES - Italia 2
JP - Giappone 2
NO - Norvegia 2
TZ - Tanzania 2
CL - Cile 1
KH - Cambogia 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 2.590
Salva come PNG Salva come JPEG
Città #
Fairfield 218
Rome 177
Singapore 128
Ashburn 117
Chandler 110
Woodbridge 92
Houston 84
Cambridge 75
Seattle 74
Wilmington 70
Santa Clara 67
Princeton 39
New York 33
Sofia 29
Beijing 27
Ann Arbor 25
Millbury 23
Lawrence 21
Helsinki 20
San Diego 20
Jakarta 19
Milan 19
San Paolo di Civitate 19
Lomé 18
Boston 15
Dearborn 15
Plano 14
Fremont 11
Los Angeles 10
Andover 9
Federal 9
Stockholm 9
Falls Church 8
Norwalk 8
Rochester 8
Bermondsey 7
Dublin 7
Florence 6
Melville 6
Toronto 6
Bari 5
Bologna 5
Chapel Hill 5
Frankfurt am Main 5
Kunming 5
Mannheim 5
Monterotondo 5
Phoenix 5
Redwood City 5
Turin 5
Vasto 5
Bremen 4
Bühl 4
London 4
Marseille 4
Moscow 4
Noci 4
Ottawa 4
Paris 4
Salerno 4
Boardman 3
Bovezzo 3
Bromley 3
Cagliari 3
Capranica 3
Castrocielo 3
Chongqing 3
Des Moines 3
Edmonton 3
Geneva 3
Lappeenranta 3
Sacramento 3
Seregno 3
Tehran 3
Treviso 3
Warsaw 3
Amsterdam 2
Bagni di Lucca 2
Bonefro 2
Buenos Aires 2
Catania 2
Cercola 2
Chioggia 2
Cisliano 2
Dar es Salaam 2
Falkenstein 2
Giessenburg 2
Hamar 2
Hong Kong 2
Lucera 2
Lyon 2
Melbourne 2
Mexico City 2
Motomachi 2
Mönchengladbach 2
Nanjing 2
Naples 2
Nikaia 2
Palermo 2
Pescorocchiano 2
Totale 1.859
Salva come PNG Salva come JPEG
Nome #
Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism 145
Genetic and metabolic predictors of hepatic fat content in a cohort of Italian children with obesity 106
Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy 105
PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress 101
Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes 101
Non-alcoholic fatty liver disease and subclinical atherosclerosis: a comparison of metabolically- versus genetically-driven excess fat hepatic storage 92
Contribution of mutations in low density lipoprotein receptor (LDLR) and lipoprotein lipase (LPL) genes to familial combined hyperlipidemia (FCHL): A reappraisal by using a resequencing approach 88
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State 85
Twelve variants polygenic score for low-density lipoprotein cholesterol distribution in a large cohort of patients with clinically diagnosed familial hypercholesterolemia with or without causative mutations 80
Analysis of Children and Adolescents with Familial Hypercholesterolemia 80
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score 79
Evaluation of the performance of dutch lipid clinic network score in an Italian fh population: the lipigen study 78
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants 78
Identification and diagnosis of patients with familial chylomicronemia syndrome (FCS): Expert Panel recommendations and proposal of an FCS Score 69
Evolving trend in the management of heterozygous familial hypercholesterolemia in Italy: a retrospective, single center, observational study 69
Nonalcoholic fatty liver disease (NAFLD), but not its susceptibility gene variants, influences the decrease of kidney function in overweight/obese children 67
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells 67
How ANGPTL3 Inhibition Will Help Our Clinical Practice? 66
Clinical and biochemical characteristics of individuals with low cholesterol syndromes: a comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia 66
HDL-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (NAFLD) 60
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease 58
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases? 57
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway 55
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content 54
Refinement of pathogenicity classification of variants associated with familial hypercholesterolemia: implications for clinical diagnosis 51
Deep Resequencing of 9 Candidate Genes Identifies a Role for ARAP1 and IGF2BP2 in Modulating Insulin Secretion Adjusted for Insulin Resistance in Obese Southern Europeans 41
EFFICACY AND SAFETY OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: THE PAN-EUROPEAN RETROSPECTIVE OBSERVATIONAL STUDY 39
Deep re-sequencing of 9 type 2 diabetes GWAS loci by comparison of extremes of dynamic indices of insulin secrection 37
ANGPTL3 deficiency alters the lipid profile and metabolism of cultured hepatocytes and human lipoproteins 37
Autosomal recessive hypercholesterolemia: update for 2020 35
Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study 33
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 32
PNPLA3 I148M gene variant is not associated with metabolic syndrome and cardiometabolic risk in non-alcoholic fatty liver disease 32
Gomaraschi M, Ossoli A, Castelnuovo S, Simonelli S, Balzarotti G, Arca M, Di Costanzo A, Sampietro T, Vaudo G, Veglia F, Franceschini G, Calabresi L 32
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification 31
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 31
Evaluation of efficacy and safety of antisense inhibition of apolipoprotein C-III with volanesorsen in patients with severe hypertriglyceridemia 29
null 29
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 29
ApoCIII: A multifaceted protein in cardiometabolic disease 28
null 28
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. 26
Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis 25
The role of lipid metabolism in shaping the expansion and the function of regulatory T cells 24
Clinical implications of monogenic versus polygenic hypercholesterolemia: long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 24
Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease 24
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 23
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents. 21
Elevated Serum Concentrations of Remnant Cholesterol Associate with Increased Carotid Intima-Media Thickness in Children and Adolescents 20
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4 19
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 18
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 15
null 15
ANGPTL3 Deficiency and Risk of Hepatic Steatosis 14
Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries 13
Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease 10
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment 10
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey 8
null 5
null 3
Clinical implications of monogenic versus polygenic hypercholesterolemia: Long-term response to treatment, coronary atherosclerosis burden, and cardiovascular events 3
Totale 2.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020300 0 0 0 0 0 40 91 51 52 35 17 14
2020/2021343 11 18 11 17 6 17 6 42 45 111 58 1
2021/2022468 12 20 22 7 56 22 19 34 46 33 133 64
2022/2023529 79 90 34 34 42 48 21 70 52 7 38 14
2023/2024505 53 50 20 32 46 101 19 15 14 45 62 48
2024/2025368 19 67 62 60 107 53 0 0 0 0 0 0
Totale 2.800